These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18130443)

  • 21. [Some characteristics of proteolytic systems of Cl. perfringens type A].
    Tel'bukh VP; Blagoveshchenskiĭ VA; Ispolatovskaia MV; Borishpolets ZI
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):93-7. PubMed ID: 4332196
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modern viewpoint on diseases caused by bacteria from the group Clostridium welchii (Cl. perfringens)].
    SAVIC A
    Vojnosanit Pregl; 1958 Jan; 15(1):55-60. PubMed ID: 13569916
    [No Abstract]   [Full Text] [Related]  

  • 23. Postabortal infection with clostridium welchii; report of two cases with special reference to oliguria and to penicillin treatment.
    BIGBY MA; JONES FA
    J Obstet Gynaecol Br Emp; 1949 Aug; 56(4):636-47. PubMed ID: 18142494
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possible extraction of collagenase by splitting bacteria Welchia perfringens].
    DJINLESKI B; KATIC RV; MRSEVIC S
    Srp Arh Celok Lek; 1956 Nov; 84(11):1235-8. PubMed ID: 13391305
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the dermotoxins of the 6 Clostridium welchii types in rabbits].
    Matthes S
    Zentralbl Bakteriol Orig; 1965 Jul; 196(4):508-15. PubMed ID: 4287430
    [No Abstract]   [Full Text] [Related]  

  • 26. Clostridium welchii infection of the pleural cavity.
    JOHNSON RW
    Edinb Med J; 1947 Aug; 54(8):447. PubMed ID: 20269371
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the effect of Cl. sporogenes proteinases on the hemolytic activity of Cl. perfringens type A toxin].
    Zhak SP; Datsenko MF
    Mikrobiol Zh; 1968; 30(6):566-8. PubMed ID: 4308969
    [No Abstract]   [Full Text] [Related]  

  • 28. The alpha antitoxin content of the international reference preparations of Clostridium welchii types B and D antitoxins.
    SKULBERG A; VAN HEYNINGEN WE
    Bull World Health Organ; 1956; 14(3):557-66. PubMed ID: 13342930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biological properties of Cl. perfringens type A, isolated from human subjects inhabiting a hermetic chamber].
    Shilov VM; Zemlianitskaia EP; Borisova OK
    Kosm Biol Aviakosm Med; 1976; 10(3):71-5. PubMed ID: 9533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The action of proteolytic enzymes of Clostridium histolyticum and Clostridium novyi on human plasma proteins].
    Schallehn G; Müller HE
    Zentralbl Bakteriol Orig A; 1973 Jun; 224(1):102-14. PubMed ID: 4147399
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of intravenous injections of Clostridium perfringens (welchii) spore (entero) toxin in the horse].
    Torres-Anjel MJ; Castro M; Cruz A; Ochoa R
    Rev Latinoam Microbiol; 1978; 20(1):31-4. PubMed ID: 220692
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacteriostatic effects of horse sera and serum fractions on Clostridium welchii Type A, and the abolition of bacteriostasis by iron salts.
    Rogers HJ
    Immunology; 1967 Mar; 12(3):285-301. PubMed ID: 4164032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of proteolytic enzymes of Clostridium acetobutylicum in aceto-butylic fermentation].
    ZALESSKAIA MI
    Mikrobiologiia; 1956; 25(5):593-9. PubMed ID: 13407444
    [No Abstract]   [Full Text] [Related]  

  • 34. Freezing or adding trypsin inhibitor to equine intestinal contents extends the lifespan of Clostridium perfringens beta toxin for diagnostic purposes.
    Macias Rioseco M; Beingesser J; Uzal FA
    Anaerobe; 2012 Jun; 18(3):357-60. PubMed ID: 22516562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of protease on the production of Clostridium perfringens alpha toxin.
    Sato H; Yamakawa Y; Ito A; Murata R
    Jpn J Med Sci Biol; 1977 Feb; 30(1):44-6. PubMed ID: 195109
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth of Clostridium welchii (BP6K).
    BOYD MJ; LOGAN MA; TYTELL AA
    J Biol Chem; 1947 Mar; 167(3):879. PubMed ID: 20287926
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on a proteolytic enzyme system of the blood. V. Activation of profibrinolysin by trypsin.
    LEWIS JH; FERGUSON JH
    Am J Physiol; 1952 Sep; 170(3):636-41. PubMed ID: 12985940
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of chronic purulent diseases with the proteolytic enzyme trypsin].
    DZIUBA K; WOLF HJ
    Medizinische; 1954 Oct; 42():1421-6. PubMed ID: 13223272
    [No Abstract]   [Full Text] [Related]  

  • 39. A rapid cultural method for the presumptive identification of Clostridium welchii.
    FELS IG
    Med Bull U S Army Force Europe Theater Off Theater Chief Surg; 1945 Jan; (27):22-4. PubMed ID: 20293508
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on proteolytic enzymes. I. Toxicology of crystalline trypsin and chymotrypsin.
    HENDLEY CD; ROBBINS KC; DERTINGER B; CLEMENTS GR; ERCOLI N
    Arch Int Pharmacodyn Ther; 1956 Apr; 106(1-2):164-77. PubMed ID: 13328223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.